By Sheri Colberg, PhD A safe and effective exercise program for people with diabetes minimizes the acute risks and long-term complications associated with physical activity while maximizing the benefits. As the benefits frequently outweigh the risks, regular participation in a variety of physical activities should be recommended and encouraged for …
Read More »Monthly Archives: May 2013
Mediforms EMR Lite
Idea Oven, LLC iOS/Free Mediforms EMR is an Electronic Medical Records (EMR) app for the iPad. All entry is done via touches so you can capture your patient history and encounter details as quickly as (or quicker than) your traditional paper forms.
Read More »Letter from the Editor, #675
Things are in full swing at AACE this weekend and we will be bringing you the most important and usable information in next week’s newsletter. One of the most talked-about insulin-delivery products is the V-Go insulin delivery device. Early results from the "SIMPLE" study followed patients who switched from …
Read More »Cholesterol Lowering Treatment Options (pdf)
Cholesterol Lowering Treatment Options (pdf) This week, we have an exclusive new Tool for Your Practice for you prepared by our talented interns, Lauren Self, UF College of Pharmacy, and Gabrielle Soussman, LECOM College of Pharmacy, summing up in a short 6 page printout, the current and available Cholesterol Lowering …
Read More »Rate of Physician Participation in ACOs Triples
The number of physicians participating in accountable care organizations (ACOs) has increased drastically since 2012, according to the 2013 Physician Compensation Report. Last year, just 8% of the nation’s physicians were either in an ACO or planned to be in one within the year. This year, 24% of respondents are …
Read More »One Can of Soda Daily Increases Risk of Diabetes by 22%
Using results from the EPIC study, researchers also found that the increase in risk fell slightly after adjusting the findings to take account of BMI. This suggests it was not simply being overweight that led to the trend, they said. A total of 350,000 individuals were questioned about their diet, …
Read More »Merck and Pfizer Collaborate to Develop New SGLT2 Drug, Ertugliflozin
There is currently fierce competition to get SGLT2 medications approved and onto the market. The first SGLT2 drug, Invokana (canagliflozin), developed by Johnson and Johnson, was approved by the FDA just recently. Ertugliflozin, which is ready for Phase III trials, will likely be marketed as a drug taken on its …
Read More »Screening Finds Retinopathy Early in Diabetes
A screening program for diabetic retinopathy diminished the likelihood of eye disease in patients with diabetes….
Read More »Insulin Resistance in Type 1 Teens Associated with Cardiorespiratory Fitness
Teens targeting strength, cardio fitness battle insulin resistance….
Read More »Discovery Raises Hope for Type 1 Diabetes Reversal
A two-step process consisting of one drug to induce immune tolerance and another to promote islet regeneration could be key to type 1 diabetes reversal….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.